DRUSOLV
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Oct 2025)
What this means for you
Registered since 28 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87588109
- Registration number
- 5764343
- Mark type
- Stylized text
- Filed
- 29 Aug 2017
- Published for opposition
- 01 May 2018
- Registered
- 28 May 2019
- Attorney of record
- Robert C. Netter, Jr.
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of the treatment and prevention of macular degeneration and other eye diseases; medical and scientific research related to the development of pharmaceutical preparations for the treatment and prevention of macular degeneration and other eye diseases
Owner
- Drusolv Therapeutics, Inc., Philadelphia, PA, US
- Drusolv Therapeutics, Inc., Philadelphia, PA, US
- Drusolv Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 28 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Sept 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 13 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 26 Apr 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Apr 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED